The effect of oral aspirin in doses known to influence in vitro platelet aggregation was evaluated in patients undergoing brachial artery catheterization. Neither arterial thrombus formation nor pulse reduction was affected in patients given aspirin when compared to controls. Aspirin in small doses does not decrease the incidence of vascular occlusion after brachial artery catheterization.
SUMMARY
The effect of oral aspirin in doses known to influence in vitro platelet aggregation was evaluated in patients undergoing brachial artery catheterization. Neither arterial thrombus formation nor pulse reduction was affected in patients given aspirin when compared to controls. Aspirin in small doses does not decrease the incidence of vascular occlusion after brachial artery catheterization.
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Arterial occlusion ASCULAR occlusion, frequently with thrombus formation, is the primary complication of brachial arteriotomy after brachial artery catheterization, reaching an incidence as high as 24% in recent studies.' 2 The development of platelet antiaggregating agents (of which aspirin is one) and our previous experience with complications of brachial artery catheterization prompted us to undertake a prospective study to observe the effects of aspirin on arterial occlusion occurring with brachial artery catheterization for coronary arteriography. Methods A consecutive series of 150 patients (125 males, 25 females) referred for coronary angiography or angiographic visualization of aortocoronary bypass grafts formed the basis of this report. Patients were informed of the nature of the study. Patients were excluded from the study for the following reasons: refusal to participate in the study, symptoms suggestive of an active duodenal ulcer, history of a bleeding disorder, or history of allergy to aspirin.
All patients were seen in the hospital the night before catheterization, at which time their axillary, brachial, radial, and ulnar pulses were graded 0-4, 0 being an absent pulse and 4 a normal pulse. Each patient was then given a capsule containing either a lactose placebo (66 patients) or 325 mg or 650 mg of aspirin (84 patients), according to a randomized list. Forty-eight Arteriotomy complications Aspirin patients had taken aspirin during the 7 days before the study and thus were assigned preferentially to the group that received aspirin. Thirty-five patients were taking anticoagulants within the 10 days prior to catheterization. Patients were catheterized in the fasting state, 12-15 hours after receiving the aspirin or placebo, and after having received 100 mg of sodium pentobarbital 15-30 min prior to the study. A diluted heparin solution (5-8 ml of a solution containing 30 ml of normal saline and 6250 units of porcine heparin) was injected intraarterially prior to insertion of the catheter and prior to repair of the arteriotomy. At the completion of the catheterization, a Fogarty catheter was passed proximally and distally to the arteriotomy site. The artery was stabilized with angled vascular clamps and repaired with interrupted 6-0 silk sutures which were wiped with sterile mineral oil. After the repair, the pulses in the catheterized limb were evaluated and graded immediately, on the patient's leaving the catheterization laboratory, and on the evening of the study. Reopening of the arteriotomy repair when necessary was performed, with thrombectomy and reclosure in the catheterization laboratory. After the procedure, the entire forearm was wrapped in a large bulky dressing, which was worn by the patient until the following morning.
The major end points of the study for the evaluation of the effect of aspirin were (1) the incidence of thrombus formation found at repair by the routine passage of a Fogarty catheter, and (2) reduction of the radial or ulnar arterial pulses after repair of the artery. Other factors analyzed included patient's age and sex, whether a previous arterial study had been performed in that limb, the presence of local atheroma or arterial spasm, the number of catheters used in each patient, the length of time that the catheter was in the artery, the total time for repair of the arteriotomy, the use of anticoagulants in the 10 days prior to study, and selected hemodynamic parameters, including mean arterial pressure, cardiac index determined by left Circulation, Volume XLVII, March 1973 ventricular dye curves, and the calculated systemic resistance. The presence of arterial spasm was deterninied bv the resistance encountered in manipulatinig the catheter and a decrease in distal pulse if no thrombus vas found on routine passage of a Fogarty catheter.
Results
Patients were grouped according to whether they received placebo (66 patients), 325 mg of aspirin (39 patients), or 650 mg of aspirin (45 patients). The groups did not differ significantly with respect to age, sex, the number of catheters used per patient, the time the catheter was in the artery, or the time for repair of the artery (table 1) .
Fifteen patients had a decrease in pulse after catheterization (table 2): 12 of the males (9.6%) and three of the females (12%). These patients did not differ in age, number of catheters used, time of catheter in artery, mean arterial pressure, cardiac index, or systemic resistance from those with normal pulses after catheterization. However, arterial thrombus formation and spasm were seen more frequently in patients with decreased pulses. The incidence of decreased pulses (a decrease of at least two grades) immediately after catheterization or by the evening of the study did not differ between the placebo and the aspirin groups (table 3) . There was no decrease in the incidence of arterial thrombi between patients who received aspirin and patients who received placebo. Thirty-five patients were taking anticoagulants prior to catheterization. Decreased or absent pulses occurred in two patients who were taking anticoagulants and in 10 patients who were not (table 3) . Though the number of observations made on decreased or absent pulses is too small to yield a statistically significant result, the lower incidence of arterial thrombus formation (5.7%) in the patients who received anticoagulants as compared to those who did not (26.1%) is significant. No hemorrhagic complications were encountered in the anticoagulated patients.
Of the 35 patients who were receiving anticoagulants, two of the 16 in the placebo group had arterial thrombus formation, while none in the aspirin groups had thrombus; these numbers are too small to derive statistical significance. No patient taking anticoagulants had arterial spasm. Of the patients receiving anticoagulants, one in the placebo group and one in the aspirin group had a decrease in pulse. The prothrombin times of the patients with anticoagulation and either placebo or aspirin were nearly identical-one and one-half the normal prothrombin time for our laboratory.
Eight patients had arteriotomy repairs reopened, thrombectomy with the Fogarty catheter, distal flush with dilute heparin, and reclosure of the arteriotomy. Five of these had distal pulses restored to precatheterization status, while three regained distal pulses only partially. Two patients had an absent pulse by the evening of the study, one with an absent radial pulse and an ulnar pulse of grade 4, and a second patient with an absent ulnar pulse (precatheterization only grade 1) and a radial pulse of grade 2. The third patient regained only a radial pulse of grade 1 and an ulnar pulse of grade 1. No patient developed ischemia of the hand or forearm.
Discussion
In recent years, the response of flowing blood to injury as well as the major role of the platelet have been clarified in both normal hemostasis and in thrombus formation.3 Platelet interaction with surfaces, platelet aggregation, and alteration of blood flow all have important roles in thrombosis. Initial arterial trauma results in platelet adhesion to subendothelial microfibrils and collagen and in Aspirin is one of many drugs that prevent collagen-induced platelet aggregation in vitro, by inhibiting the release of platelet constituents and endogenous platelet ADP.4 Oral administration of aspirin in high doses to rabbits prolongs bleeding time and platelet survival and markedly decreases thrombus deposit in an extracorporeal shunt model.6 Danese et al.7 have shown that aspirin in a dose of 600 mg given orally to dogs significantly decreases the incidence of chemically induced total occlusion in superficial femoral and axillary artery segments that are 3-4 mm in diameter.
Clinically, aspirin's antithrombotic effect has been tested chiefly in venous thrombosis. O'Brien and colleagues8 suggest that neither low-dose (600 mg) nor high-dose (2.4 g) aspirin given to postoperative patients prevents deep venous thrombosis, as detected by the 1251-labeled fibrinogen technic. In a clinical study after Vitallium-mold hip arthroplasty, Salzman and associates9 noted a similar degree of protection against venous thromboembolic complications in an aspirin-treated group, as compared to a warfarin-treated group. There are distinct differences in the type of thrombus noted in the venous vs arterial sides of the circulation, and considering the acknowledged primacy of the platelet in thrombus formation in the arterial circuit, most workers agree that proper evaluation of aspirin's antithrombotic effect requires an arterial model.10
Campion et al.1" reported data from our institution on 342 brachial arteriotomies done during 1968 and 1969 and noted a decreased radial pulse in 12.2% of patients immediately after closure of the arteriotomy. They found that 14.0% of patients developed an arterial thrombus. Three patients (0.9%) had an absent radial pulse when dismissed from the hospital. This correlates closely with data from our current placebo group and demonstrates the relative constancy of arterial thrombus formation and arterial occlusion in a given laboratory.
Aspirin doses of 325 mg and 650 mg were chosen on the basis of in vitro human studies indicating that, although each patient tends to have a characteristic response to oral aspirin when platelet aggregation is tested in vitro, the effect is maximal immediately, and there is no evidence of a cumulative effect at higher doses.8 In fact, in vitro platelet effects of very small doses of aspirin persist for several days. 12 Aspirin, under the conditions of this study, had no effect on the incidence of either arterial thrombus formation or pulse reduction after brachial artery catheterization.
Possible explanations for failure in this clinical setting include inadequate dose, improper timing of administration of medication, and the nature of the model used. Data on rabbits suggest an antithrombotic effect at higher doses of aspirin, while lower doses had none.13 Further studies with higher doses of aspirin would be necessary to settle this question. Brachial arteriotomy, in addition to the platelet adhesion and aggregation that results from exposure to subendothelial material after arteriotomy repair, involves initially injury to the entire vessel wall. Local tissue-thromboplastin release with activation of the clotting mechanism results and contributes to thrombus formation. Small doses of aspirin may not be sufficient to overcome all the thrombogenic stimuli of the model. This is supported by the decreased incidence of arterial thrombus formation in the anticoagulated group, in which we would expect the anticoagulant to interfere with fibrin formation.
Our study was designed to evaluate the antithrombotic effect of small doses of aspirin in this model. Due to the limitations of the model, no general conclusions can be drawn about the usefulness of aspirin as an antithrombotic agent.
The incidental finding of decreased thrombus formation and a lower incidence of decreased or absent pulses in the anticoagulated group is of interest. The number of observations is small but support a protective effect of systemic anticoagulation.
Careful repair of arteriotomy sites and the use of the Fogarty catheter in experienced hands are important in decreasing the incidence of thrombotic complications after brachial arteriotomy.14 Our data suggest that, although small doses of aspirin do not decrease thrombotic complications after brachial arteriotomy, systemic anticoagulation does.
